AI Insight
This perspective article proposes a novel hypothesis linking oligodendrocyte dysfunction to cognitive decline in Alzheimer's disease. The author suggests that adaptive myelination in gray matter, a process where oligodendrocytes modify myelin in response to neural activity to support changes in brain function, may be disrupted in Alzheimer's patients. This perturbation of activity-dependent myelination could represent an underappreciated mechanism contributing to the cognitive symptoms characteristic of the disease.
Why it matters
Understanding how oligodendrocyte dysfunction contributes to Alzheimer's disease could open new therapeutic avenues beyond current approaches that focus primarily on amyloid plaques and tau tangles. If adaptive myelination proves critical for maintaining cognitive function, interventions targeting oligodendrocyte health or myelin plasticity might help preserve cognition in Alzheimer's patients.
Understand the Science
by Charles ffrench-Constant
The consequences of oligodendrocyte involvement in Alzheimer’s disease are poorly understood. Could a key role of gray-matter oligodendrocytes—activity-dependent adaptive myelination to sustain changes in activity—be perturbed, leading to cognitive loss?
The consequences of oligodendrocyte involvement in Alzheimer’s disease are poorly understood. This Perspective suggests that activity-dependent adaptive myelination, a key role of grey-matter oligodendrocytes, could be perturbed, leading to cognitive loss.
Source: Does perturbed adaptive myelination contribute to cognitive dysfunction in Alzheimer’s disease?